US Patent 10954287 Ras binding peptides and methods of use
Patent 10954287 was granted and assigned to Ra Pharmaceuticals on March, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 14 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+239 characters)
Article
Patent abstract
The present invention provides Ras modulators including inhibitors and/or antagonists of Ras, Ras binding, and Ras-dependent cell signaling activity. Also provided are methods of utilizing the Ras modulators as therapeutics.
Edits on 9 Oct, 2023
Golden AI
Edits made to:
Infobox (+10 properties)
Infobox
Patent Inventor Names
Douangsone D. Vadysirisack0
Douglas A. Treco0
Guo-Qing Tang0
Kathleen Seyb0
Kristopher Josephson0
Nathan Ezekiel Nims0
Ping Ye0
Sylvia Tobe0
Yili Sun0
Zhong Ma0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
109542870
Date of Patent
March 23, 2021
0Patent Application Number
160937620
Date Filed
April 14, 2017
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 10 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10954287 Ras binding peptides and methods of use
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10954287
Date of patent
March 23, 2021
Patent application number
16093762
Date Filed
April 14, 2017
Patent primary examiner
Find more entities like US Patent 10954287 Ras binding peptides and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.